Reliability and validity of Turkish version of COPD assessment test

Yorgancıoğlu, Arzu; Polatlı, Mehmet; Aydemi̇r, Ömer; Demirci, Nilgün Yılmaz; Kırkıl, Gamze; Naycı, Sibel; Köktürk, Nurdan; Uysal, Atilla; Akdemir, Selim Erkan; Özgür, Eylem Sercan; Gunakan, Gonca

doi:10.5578/tt.4321

Cited by 48 publications

(30 citation statements)

References 2 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The total score ranges from 0 to 40 points, with lower scores indicating better health status. Cronbach's alpha coefficient was 0.91, and a total item correlation for each item ranged between 0.62 and 0.79 in the Turkish validity and reliability study (Yorgancıoğlu et al, 2012).…”

Section: Methodsmentioning

confidence: 97%

Relationship between symptom burden, medication adherence and spiritual well‐being in patients with chronic obstructive pulmonary disease

Helvaci

İzgü

Özdemir

2020

Journal of Clinical Nursing

View full text Add to dashboard Cite

Aims and objectives To investigate the relationship between symptom burden, medication adherence and spiritual well‐being in patients with chronic obstructive pulmonary disease (COPD). Background The relationship between spirituality and medication adherence has been investigated in different chronic conditions. However, the relationship between symptom burden, medication adherence and spiritual well‐being in patients with COPD has not been explored. Design A descriptive correlational study design was adopted. Methods A total of 112 patients with COPD were included in the study. Data were collected using the COPD Assessment Test (CAT), the Adherence to Refills and Medications Scale‐7 (ARMS‐7) and the Functional Assessment of Chronic Illness Therapy‐Spiritual Well‐Being Scale (FACIT‐Sp). The data were analysed using descriptive and correlational statistics. The Strengthening the Reporting of Observational studies in Epidemiology (STROBE) Checklist was used. Results The CAT score was significantly higher in patients on long‐term oxygen therapy and those who had more than three comorbid conditions (p < .05). The mean score of ARMS‐7 was significantly associated with age (p < .05). Current smokers had higher ARMS‐7 and lower FACIT‐Sp scores (p < .001). The FACIT‐Sp score was negatively and moderately associated with the CAT and ARMS‐7 scores (p < .001). Conclusion This study concluded that individuals with higher spiritual well‐being had lower symptom burden and higher medication adherence. The need for long‐term oxygen therapy and a high number of comorbid conditions were associated with increased symptom burden. Current smokers had lower spiritual well‐being and medication adherence. Relevance to clinical practice Spiritual well‐being should be evaluated when assessing symptom burden and medication adherence in clinical practice. In addition, further studies examining the causal relationship between symptom burden, spiritual well‐being and medication adherence in different populations are warranted.

show abstract

Section: Methodsmentioning

confidence: 97%

Relationship between symptom burden, medication adherence and spiritual well‐being in patients with chronic obstructive pulmonary disease

Helvaci

İzgü

Özdemir

2020

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…The CAT questionnaire has been translated to other languages including Japanese where it has had a Chroncach's alpha coefficient of 0.891 and shown high correlation with scores from the SGRQ [17]. This questionnaire was also translated to Chinese and Turkish and had acceptable report [18,19]. The CAT questionnaire has been used to follow the condition of patients with COPD, particularly for evaluating health improvement with rehabilitation and recovery from disease exacerbation [20][21][22].…”

Section: Discussionmentioning

confidence: 99%

Validation of the COPD Assessment Test in Patients with COPD in Iran

Fakharian¹,

Masouleh²,

Karimzadeh³

et al. 2017

Chron Obstruct Pulmon Dis

View full text Add to dashboard Cite

Background: Chronic obstructive pulmonary diseases (COPD) is among the most important causes of chronic disease in adulthood. COPD assessment test (CAT) and Saint George Respiratory Questionnaire (SGRQ) are two health related quality of life questioners validated for application in patients with COPD. Our purpose was to evaluate the validity and reliability of the short and easily translated CAT questionnaire for COPD patients.

show abstract

“…Symptom severity was assessed with the eight-item patient-reported outcome measure, the COPD Assessment Test (CAT) 18. The Turkish version of the CAT was shown to be a valid and reliable tool 19. Spirometry was performed before and after administration of short-acting β 2 -agonist (albuterol) by using Vmax Encore System (Sensormedics, Viasys, Yorba Linda, CA, USA) in accordance with ATS/ERS recommendations 20.…”

Section: Methodsmentioning

confidence: 99%

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

Dilektaşlı¹,

Cetinoglu²,

Uzaslan³

et al. 2017

COPD

View full text Add to dashboard Cite

IntroductionChemokine (C-C motif) ligand 18 (CCL-18) has been shown to be elevated in chronic obstructive pulmonary disease (COPD) patients. This study primarily aimed to evaluate whether the serum CCL-18 level differentiates the frequent exacerbator COPD phenotype from infrequent exacerbators. The secondary aim was to investigate whether serum CCL-18 level is a risk factor for exacerbations requiring hospitalization.Materials and methodsClinically stable COPD patients and participants with smoking history but normal spirometry (NSp) were recruited for the study. Modified Medical Research Council Dyspnea Scale, COPD Assessment Test, spirometry, and 6-min walking test were performed. Serum CCL-18 levels were measured with a commercial ELISA Kit.ResultsSixty COPD patients and 20 NSp patients were recruited. Serum CCL-18 levels were higher in COPD patients than those in NSp patients (169 vs 94 ng/mL, P<0.0001). CCL-18 level was significantly correlated with the number of exacerbations (r=0.30, P=0.026), although a difference in CCL-18 values between infrequent and frequent exacerbator COPD (168 vs 196 ng/mL) subgroups did not achieve statistical significance (P=0.09). Serum CCL-18 levels were significantly higher in COPD patients who had experienced at least one exacerbation during the previous 12 months. Overall, ROC analysis revealed that a serum CCL-18 level of 181.71 ng/mL could differentiate COPD patients with hospitalized exacerbations from those who were not hospitalized with a 88% sensitivity and 88.2% specificity (area under curve: 0.92). Serum CCL-18 level had a strong correlation with the frequency of exacerbations requiring hospitalization (r=0.68, P<0.0001) and was found to be an independent risk factor for hospitalized exacerbations in the multivariable analysis.ConclusionCCL-18 is a promising biomarker in COPD, as it is associated with frequency of exacerbations, particularly with severe COPD exacerbations requiring hospitalization, as well as with functional parameters and symptom scores.

show abstract

Reliability and validity of Turkish version of COPD assessment test

Abstract: It is demonstrated The Turkish version of COPD Assessment Tool is reliable and valid.

Cited by 48 publications

References 2 publications

Relationship between symptom burden, medication adherence and spiritual well‐being in patients with chronic obstructive pulmonary disease

Relationship between symptom burden, medication adherence and spiritual well‐being in patients with chronic obstructive pulmonary disease

Validation of the COPD Assessment Test in Patients with COPD in Iran

Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization

Contact Info

Product

Resources

About